Page last updated: 2024-10-29

ketamine and Hemimegalencephaly

ketamine has been researched along with Hemimegalencephaly in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Hemimegalencephaly: Rare MALFORMATIONS OF CORTICAL DEVELOPMENT, GROUP I characterized by the enlargement of one side of the brain. It is associated with seizures, partial paralysis, and mental retardation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Brisca, G1
Pirlo, D1
Prato, G1
Tortora, D1
Siri, L1
Nobili, L1
Tardini, G1
Consales, A1
Moscatelli, A1
Buratti, S1

Other Studies

1 other study available for ketamine and Hemimegalencephaly

ArticleYear
Efficacy of Ketamine Use in Refractory Status Epilepticus Associated With Hemimegalencephaly.
    Pediatric emergency care, 2022, Mar-01, Volume: 38, Issue:3

    Topics: Anticonvulsants; Hemimegalencephaly; Humans; Ketamine; Status Epilepticus

2022